Table 2: Comparison in means of VDR, IL-6 and TNF-α level in each group based on the observation time.
Groups |
VDR level (ng/mL) |
Baseline |
4th day |
10th day |
30th day |
p value* |
Group A (antibiotic) |
2.98±1.09 |
6.95±1.32 |
15.04±2.37 |
16.35±2.27 |
0.000 |
Group B (placebo) |
3.82±1.81 |
7.95±1.71 |
7.93±1.42 |
9.28±1.51 |
0.000 |
Group C (Control) |
2.94±1.07 |
3.09±1.42 |
2.63±1.12 |
3.06±0.96 |
0.495 |
Groups |
IL-6 level (pg/mL) |
p value* |
Group A (antibiotic) |
109.25±29.21 |
481.72±44.10 |
465.58±45.85 |
198.90±31.49 |
0.000 |
Group B (placebo) |
125.71±40.12 |
248.87±32.75 |
222.84±37.20 |
197.34±39.89 |
0.000 |
Group C (Control) |
103.55±22.98 |
112.25±27.96 |
89.63±19.68 |
85.71±17.27 |
0.055 |
Groups |
TNF-α level (pg/mL) |
p value* |
Group A (antibiotic) |
96.62±21.90 |
304.88±38.31 |
294.01±24.34 |
168.35±19.09 |
0.000 |
Group B (placebo) |
98.96±25.95 |
198.46±34.65 |
183.73±10.80 |
157.77±21.59 |
0.000 |
Group C (Control) |
95.50±20.01 |
95.60±21.86 |
91.13±16.95 |
93.98±15.26 |
0.801 |
* Repeated Measure ANOVA Test, with values are mean±SD n=5, p-value < 0.05 is considered significant